FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2092457458> ?p ?o ?g. }

• W2092457458 endingPage "312" @default.
• W2092457458 startingPage "303" @default.
• W2092457458 abstract "Abstract Prior studies have shown that implant surface roughness affects osteoblast proliferation, differentiation, matrix synthesis, and local factor production. Further, cell response is modulated by systemic factors, such as 1,25(OH)2D3 and estrogen as well as mechanical forces. Based on the fact that peri-implant bone healing occurs in a site containing elevated amounts of prostaglandin E2 (PGE2), the hypothesis of the current study is that PGE2 and arachidonic acid (AA), the substrate used by cyclooxygenase to form PGE2, influence osteoblast response to implant surface roughness. To test this hypothesis, 4 different types of commercially pure titanium (cpTi) disks with surfaces of varying roughness (smooth Ti, Ra 0.30 μm; smooth and acid etched Ti [SAE Ti], Ra 0.40 μm; rough Ti, Ra 4.3 μm; rough and acid etched Ti [RAE Ti], Ra 4.15μm) were prepared. MG63 osteoblasts were seeded onto the surfaces, cultured to confluence, and then treated for the last 24 hours of culture with AA (0, 0.1, 1, and 10 nM), PGE2 (0, 1, 10, 25, and 100 nM), or the general cyclooxygenase inhibitor indomethacin (0 or 100 nM). At harvest, the effect of treatment on cell proliferation was assessed by measuring cell number and [3H]-thymidine incorporation, and the effect on cell differentiation was determined by measuring alkaline phosphatase (ALP) specific activity. The effect of AA and PGE2 on cell number was somewhat variable but showed a general decrease on plastic and smooth surfaces and an increase on rough surfaces. In contrast, [3H]-thymidine incorporation was uniformly decreased with treatment on all surfaces. ALP demonstrated the most prominent effect of treatment. On smooth surfaces, AA and PGE2 dose-dependently increased ALP, while on rough surfaces, treatment dose-dependently decreased enzyme specific activity. Indomethacin treatment had either no effect or a slightly inhibitory effect on [3H]-thymidine incorporation on all surfaces. In contrast, indomethacin inhibited ALP on smooth surfaces and stimulated ALP on rough. Taken together, the results indicate that both AA and PGE2 influence osteoblast response by promoting osteoblast differentiation on smooth surfaces, while inhibiting it on rough surfaces. Because implants with rough surfaces are acknowledged to be superior to those with smooth surfaces, these results suggest that use of nonsterioidal anti-inflammatory drugs to block PGE2 production and reduce inflammation may be beneficial in the postoperative period after implant placement. They also indicate that manipulation of the AA metabolic pathway may offer a new therapeutic approach for modulating bone healing after implant placement. Because peri-implant healing takes place in a complex cellular environment quite different from the one used in the present study, additional work will be necessary to substantiate these possibilities." @default.
• W2092457458 created "2016-06-24" @default.
• W2092457458 creator A5016398911 @default.
• W2092457458 creator A5027868543 @default.
• W2092457458 creator A5046003294 @default.
• W2092457458 creator A5047763445 @default.
• W2092457458 creator A5062165830 @default.
• W2092457458 creator A5073060614 @default.
• W2092457458 creator A5083865745 @default.
• W2092457458 creator A5086594425 @default.
• W2092457458 date "2008-12-01" @default.
• W2092457458 modified "2023-10-17" @default.
• W2092457458 title "Arachidonic Acid and Prostaglandin E2 Influence Human Osteoblast (MG63) Response to Titanium Surface Roughness" @default.
• W2092457458 cites W1498627601 @default.
• W2092457458 cites W1507854122 @default.
• W2092457458 cites W1517312424 @default.
• W2092457458 cites W1759838968 @default.
• W2092457458 cites W1846656465 @default.
• W2092457458 cites W1963697404 @default.
• W2092457458 cites W1964005120 @default.
• W2092457458 cites W1971852788 @default.
• W2092457458 cites W1976012755 @default.
• W2092457458 cites W1982292810 @default.
• W2092457458 cites W1984588551 @default.
• W2092457458 cites W1996144176 @default.
• W2092457458 cites W1997036536 @default.
• W2092457458 cites W2007916900 @default.
• W2092457458 cites W2009091144 @default.
• W2092457458 cites W2010278203 @default.
• W2092457458 cites W2014404589 @default.
• W2092457458 cites W2018655931 @default.
• W2092457458 cites W2019695236 @default.
• W2092457458 cites W2023112243 @default.
• W2092457458 cites W2023194934 @default.
• W2092457458 cites W2025601595 @default.
• W2092457458 cites W2026649265 @default.
• W2092457458 cites W2032342275 @default.
• W2092457458 cites W2032470529 @default.
• W2092457458 cites W2043562635 @default.
• W2092457458 cites W2049506397 @default.
• W2092457458 cites W2049816406 @default.
• W2092457458 cites W2051826552 @default.
• W2092457458 cites W2057421373 @default.
• W2092457458 cites W2060994483 @default.
• W2092457458 cites W2067302890 @default.
• W2092457458 cites W2076841267 @default.
• W2092457458 cites W2078978436 @default.
• W2092457458 cites W2081132473 @default.
• W2092457458 cites W2093668374 @default.
• W2092457458 cites W2093883262 @default.
• W2092457458 cites W2109293470 @default.
• W2092457458 cites W2113524103 @default.
• W2092457458 cites W2118454196 @default.
• W2092457458 cites W2134783974 @default.
• W2092457458 cites W2136881572 @default.
• W2092457458 cites W2143719721 @default.
• W2092457458 cites W2151005356 @default.
• W2092457458 cites W2155442777 @default.
• W2092457458 cites W2170139878 @default.
• W2092457458 cites W2626246102 @default.
• W2092457458 cites W4238600219 @default.
• W2092457458 doi "https://doi.org/10.1563/1548-1336-34.6.303" @default.
• W2092457458 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19133484" @default.
• W2092457458 hasPublicationYear "2008" @default.
• W2092457458 type Work @default.
• W2092457458 sameAs 2092457458 @default.
• W2092457458 citedByCount "11" @default.
• W2092457458 countsByYear W20924574582012 @default.
• W2092457458 countsByYear W20924574582013 @default.
• W2092457458 countsByYear W20924574582015 @default.
• W2092457458 countsByYear W20924574582016 @default.
• W2092457458 countsByYear W20924574582017 @default.
• W2092457458 countsByYear W20924574582018 @default.
• W2092457458 countsByYear W20924574582020 @default.
• W2092457458 countsByYear W20924574582021 @default.
• W2092457458 crossrefType "journal-article" @default.
• W2092457458 hasAuthorship W2092457458A5016398911 @default.
• W2092457458 hasAuthorship W2092457458A5027868543 @default.
• W2092457458 hasAuthorship W2092457458A5046003294 @default.
• W2092457458 hasAuthorship W2092457458A5047763445 @default.
• W2092457458 hasAuthorship W2092457458A5062165830 @default.
• W2092457458 hasAuthorship W2092457458A5073060614 @default.
• W2092457458 hasAuthorship W2092457458A5083865745 @default.
• W2092457458 hasAuthorship W2092457458A5086594425 @default.
• W2092457458 hasConcept C107365816 @default.
• W2092457458 hasConcept C12554922 @default.
• W2092457458 hasConcept C134018914 @default.
• W2092457458 hasConcept C141071460 @default.
• W2092457458 hasConcept C159985019 @default.
• W2092457458 hasConcept C160160445 @default.
• W2092457458 hasConcept C181199279 @default.
• W2092457458 hasConcept C185592680 @default.
• W2092457458 hasConcept C191897082 @default.
• W2092457458 hasConcept C192562407 @default.
• W2092457458 hasConcept C202751555 @default.
• W2092457458 hasConcept C21547065 @default.
• W2092457458 hasConcept C2777198256 @default.
• W2092457458 hasConcept C2777956040 @default.

• next